Loading...
Erythropoietin and diabetes mellitus
Erythropoietin (EPO) is a 30.4 kDa growth factor and cytokine that governs cell proliferation, immune modulation, metabolic homeostasis, vascular function, and cytoprotection. EPO is under investigation for the treatment of variety of diseases, but appears especially suited for the treatment of diso...
Na minha lista:
| Udgivet i: | World J Diabetes |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4620106/ https://ncbi.nlm.nih.gov/pubmed/26516410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v6.i14.1259 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|